The specialized chemical manufacturer reported revenue of ¥93.08 billion, a marginal decrease from the ¥94.36 billion recorded during the same period last year. While the top line softened, the company’s operating profit climbed to ¥6.18 billion, up from ¥6.04 billion, indicating that the firm successfully navigated rising costs to protect its margins during the first three quarters of the fiscal year.
Divergence in Earnings Performance
The divergence between operational success and final earnings was stark. Net profit for the period tumbled to ¥6.70 billion, representing a significant drop from the ¥10.15 billion reported a year prior. This decline directly impacted shareholder returns, with earnings per share falling to ¥390.99 from ¥591.65 in the previous year.According to the financial statement, which follows Japanese accounting standards, the company maintained stable pretax growth despite the net income volatility:
- Operating profit rose to ¥6.18 billion from ¥6.04 billion.
- Pretax profit increased to ¥6.93 billion from ¥6.49 billion.
- Total revenue saw a year-on-year contraction of approximately 1.4%.


Comments (0)
No comments yet. Be the first!